Cargando…
rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441447/ http://dx.doi.org/10.1186/1742-4690-9-S2-O72 |
_version_ | 1782243291686764544 |
---|---|
author | Bart, P Huang, Y Frahm, N Karuna, S Allen, M Kochar, NK Chappuis, S Gaillard, J Graham, B Pantaleo, G |
author_facet | Bart, P Huang, Y Frahm, N Karuna, S Allen, M Kochar, NK Chappuis, S Gaillard, J Graham, B Pantaleo, G |
author_sort | Bart, P |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3441447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34414472012-09-18 rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses Bart, P Huang, Y Frahm, N Karuna, S Allen, M Kochar, NK Chappuis, S Gaillard, J Graham, B Pantaleo, G Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441447/ http://dx.doi.org/10.1186/1742-4690-9-S2-O72 Text en Copyright ©2012 Bart et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Bart, P Huang, Y Frahm, N Karuna, S Allen, M Kochar, NK Chappuis, S Gaillard, J Graham, B Pantaleo, G rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title | rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title_full | rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title_fullStr | rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title_full_unstemmed | rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title_short | rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses |
title_sort | rad5 prime/nyvac-b boost regimen is superior to nyvac-b prime/rad5 boost regimen for both response rates and magnitude of cd4 and cd8 t-cell responses |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441447/ http://dx.doi.org/10.1186/1742-4690-9-S2-O72 |
work_keys_str_mv | AT bartp rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT huangy rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT frahmn rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT karunas rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT allenm rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT kocharnk rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT chappuiss rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT gaillardj rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT grahamb rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses AT pantaleog rad5primenyvacbboostregimenissuperiortonyvacbprimerad5boostregimenforbothresponseratesandmagnitudeofcd4andcd8tcellresponses |